Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Liberty Latin America-A
LILA
US Stock MarketDetailed Quotes
IMNN Imunon
- 0.8462
- -0.0304-3.47%
Trading Apr 24 12:13 ET
12.37MMarket Cap-0.52P/E (TTM)
0.8871High0.8320Low4.20KVolume0.8766Open0.8766Pre Close3.58KTurnover0.03%Turnover RatioLossP/E (Static)14.62MShares3.650052wk High2.92P/B10.48MFloat Cap0.640052wk Low--Dividend TTM12.39MShs Float145293.7500Historical High--Div YieldTTM6.29%Amplitude0.4800Historical Low0.8520Avg Price1Lot Size
About Imunon Company
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Company Profile
SymbolIMNN
Company NameImunon
Listing DateFeb 8, 2008
Founded1982
CEODr. Stacy R. Lindborg, PhD
MarketNASDAQ
Employees33
Fiscal Year Ends12-31
Address997 Lenox Drive,Suite 100
CityLawrenceville
ProvinceNew Jersey
CountryUnited States of America
Zip Code08648
Phone1-609-896-9100
Websitehttp://imunon.com
Company Executives
- Name
- Position
- Salary
- Dr. Stacy R. Lindborg, PhD
- Director, President and Chief Executive Officer
- 44.10K
- Dr. Douglas Faller, M.D.
- Chief Medical Officer
- --
- David Gaiero
- Chief Financial Officer and Chief Accounting Officer
- --
- Dr. Khursheed Anwer, M.B.A.,PhD
- Executive Vice President and Chief Scientific Officer
- 680.16K
- Michael H. Tardugno
- Executive Chairman of the Board
- --
- Christine A. Pellizzari
- Independent Director
- 47.70K
- James E. Dentzer
- Independent Director
- 61.20K
- Frederick J. Fritz
- Independent Director
- 106.20K
- Dr. Donald Braun, PhD
- Independent Director
- 72.90K
- Susan Eylward
- General Counsel and Corporate Secretary
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
